Since its inception, GENIE has established itself as a pioneering clinico-genomic initiative, dedicated to providing open-access data through the collaborative efforts of its strategic partners: Sage Bionetworks and the cBioPortal for Cancer Genomics at Memorial Sloan Kettering (MSK).
- Sage Bionetworks is a nonprofit research organization at the forefront of open science. Its multidisciplinary team—including scientists, engineers, designers, and governance experts—develops integrative technology platforms that enhance biomedical research through data-sharing, analytics, and reproducibility.
- cBioPortal for Cancer Genomics at MSK is a globally recognized platform providing interactive visualization, analysis, and downloads of large-scale cancer genomics datasets. It serves as an essential tool for researchers, enabling meaningful insights into cancer biology, treatment response, and patient outcomes.
Through these collaborations, the GENIE registry aggregates, harmonizes, and links clinical-grade, next-generation sequencing (NGS) data with real-world clinical outcomes collected from nearly every cancer patient treated at our participating institutions.
GENIE is built on a foundation of openness, transparency, and inclusivity, ensuring that its data remains accessible to the global cancer research community. In an era where many commercial entities are locking clinico-omic data in private repositories, GENIE remains steadfast in its commitment to open data-sharing—advancing cancer research for the benefit of all.